India is the largest manufacturer of vaccines in the world, accounting for 80% of all vaccines consumed in the country, and the third largest for pharmaceuticals. But ask any formulation company what is their real chemistry and the honest answer is uncomfortable \u2013 China. Almost 70 per cent of the major starting materials and intermediates used in the production of bulk drugs in India still come from few suppliers in China whose lead times and prices are not under the control of the founder. That singular dependency is the doorway for anybody serious with regards to pharma intermediate manufacturing India projects today. This is not formulation manufacturing, which already has hundreds of small units competing for slim profit margins on branded generics. One step up the stream are the intermediate and KSM manufacturing, which are not quite so real a chemistry but are far less congested. The government has also become cognizant of this change and is funding it with cash.<\/p>\n